Ixekizumab Improves Functioning and Health in the Treatment of Radiographic Axial Spondyloarthritis: Week 52 Results from 2 Pivotal Studies

U. Kiltz*, J.C.C. Wei, D. van der Heijde, F. van den Bosch, J.A. Walsh, A. Boonen, L.S. Gensler, T. Hunter, H. Carlier, Y. Dong, X.Q. Li, R. Bolce, V. Strand, J. Braun

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Web of Science)
Original languageEnglish
Pages (from-to)188-197
Number of pages10
JournalJournal of Rheumatology
Volume48
Issue number2
DOIs
Publication statusPublished - 1 Feb 2021

Keywords

  • ankylosing spondylitis
  • ASAS Health Index
  • EQ-5D
  • ixekizumab
  • radiographic axial spondyloarthritis
  • SF-36
  • QUALITY-OF-LIFE
  • ANKYLOSING-SPONDYLITIS
  • MONOCLONAL-ANTIBODY
  • RHEUMATOID-ARTHRITIS
  • PREVALENCE
  • SECUKINUMAB
  • SAMPLE
  • INDEX
  • ASAS
  • HI

Cite this